

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fabry disease | D000795 | Orphanet_324 | E75.21 | 1 | — | 2 | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
| Drug common name | Lucerastat |
| INN | lucerastat |
| Description | Lucerastat is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Small molecule |
| Drug class | enzyme inhibitors |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO |
| PDB | — |
| CAS-ID | 141206-42-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1086997 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | GVS3YDM418 (ChemIDplus, GSRS) |
